Rapportage Audit Commissie Doping : periode: maart 2003 t/m augustus 2003 / C.A. Segaar, H.P.F. Koppeschaar, C. van Bentum. - Arnhem : Audit Commissie Doping, 2003.
- Rapportage ten behoeve van de Algemene Vergadering NOC*NSF 18 november 2003.
- Halfjaarlijkse rapportage aan de Algemene Vergadering van NOC*NSF, het bestuur NOC*NSF, de staatssecretaris van Volksgezondheid, Welzijn en Sport en het bestuur van het NeCeDo.

Inhoud:

- Hfdst. 1 inleiding
- Hfdst. 2 aanbevelingen en samenvatting;
- Hfdst. 3 taakstelling Audit Commissie Doping;
- Hfdst. 4 rapportage;
- Hfdst. 5 gegevens verzameling;
- Hfdst. 6 beveiliging netwerk;
- Hfdst. 7 toelichting schema rapportage;
- Hfdst. 8 conclusies;
- Hfdst. 9 rapportageschema;
- Bijlage aantal controles per bond in 2003, toegewezen vanuit NOC*NSF.

AUSTRALIAN SPORTS DRUG AGENCY 2003-04 ANNUAL REPORT
© Commonwealth of Australia
ISSN 1037-378

Table of contents
Table of contents iv
Figures 1
Acronyms 2
About this report 3
Chairperson’s message 5
ASDA snapshot: 2003-04 10
Organisational overview 12
Australia’s anti-doping framework 14
ASDA’s corporate structure 14
Deterrence 16
Drug testing 17
Education and information 24
Implementing effictive anti-doping policies 29
Research 31
Obtaining information to enhance ASDA’s deterrence program 31
International response 34
Facilitating a harmonised international response to doping 34
Representing Australia internationally 36
Business improvement 40
Effective corporate governance 40
Responding to business opportunities 43
Employing best practice 44
Managing community service obligations 45
People 48
Developing staff potential 48
Learning and development 49
Attracting and retaining staff 50
31165 ASDA ANNUAL REPORT 3 22/11/04 4:23 PM Page iv
TABLE OF CONTENTS ASDA ANNUAL REPORT 03:04 PAGE V
ASDA’s Corporate governance 54
The ASDA Board 54
Audit Committee 57
Senior management staff 57
Management committees 58
Staffing overview 58
Strategic and operational plans 58
Reporting compliance 58
Legislative and regulatory requirements 59
Ministerial directions 59
Ecologically sustainable development and environmental performance 59
Equal employment and opportunity 60
Ethical standards 60
Occupational health and safety (OH&S) 61
Discretionary grants 61
Freedom of information (FOI) 61
Risk management and fraud control 62
Social justice and equity 62
Provision of information 62
Commonwealth disability strategy 62
Australian Government Branding 62
Australian Sports Drug Medical Advisory Committee 64
Therapeutic Use Exemption (TUE) approvals
for the legitimate use of prohibited substances 64
ASDMAC members 64
ASDMAC’s achievements 65
ASDMAC’s TUE approval process 66
International TUE trends 67
ASDMAC resources 67
Glossary 70
Appendices 72
Appendix A: ASDA Strategic Plan performance outcomes 2003-04 72
Appendix B: Drug testing statistics 2003-04 73
Appendix C: Register of Notifiable Events (RNE) 86
Appendix D: List of International Incidences (LII) 88
Appendix E: Entries on RNE and LII from previous years where
outcomes were to be advised 89
Appendix F: International anti-doping arrangements and drug testing agreements 90
Appendix G: Financial statements 93
Appendix H: 2001-05 ASDA Strategic Plan 137
Appendix I: Powers of the Minister under the ASDA Act 138
Appendix J: The objects, functions and powers of the Agency as specified in the ASDA Act 139
Appendix K: Portfolio Budget Statements performance summary 141
Appendix L: Summary of Portfolio Budget Statements by outcome 142
Appendix M: ASDMAC functions (excerpt from ASDA Regulations 1999) 143
Appendix N: ASDMAC TUE applications by sport 2003-04 144
Index 148
Figures
Figure 1: Australia’s anti-doping framework
Figure 2: ASDA’s corporate structure
Figure 3: Deterrent effect of ASDA’s programs 2000-04
Figure 4: Adverse drug test result trends 1998-2004
Figure 5: Client awareness of ASDA’s education services
Figure 6: Distribution of ASDA’s education resources
Figure 7: ASDA’s client engagement
Figure 8: ASDA’s corporate governance assessment ratings 2002-03 versus 2003-04
Figure 9: ASDA staff survey satisfaction ratings 1998-2003
Figure 10: ASDA Board details as at 30 June 2004
Figure 11: ASDA Audit Committee details as at 30 June 2004
Figure 12: ASDMAC’s budget 2003-04

AUSTRALIAN SPORTS DRUG AGENCY 2002-03 ANNUAL REPORT
© Commonwealth of Australia
ISSN 1037-378

Contents
Figures vi
Acronyms vi
Chairperson’s report 01
ASDA snapshot: 2002–2003 05
ASDA in Australia’s anti-doping framework 08
ASDA’s corporate structure 08
Deterrence 09
Drug testing 10
Education 14
Research 18
Reducing the supply of banned drugs 19
International response 21
Facilitating harmonised international response 22
Representing Australia internationally 24
Business improvement 27
Effective corporate governance 28
Responding to business opportunities 29
Employing best practice 30
Managing community service obligations 30
People 31
Developing staff potential 32
Learning and development 33
Attracting and retaining staff 33
Corporate governance 35
Australian Sports Drug Medical Advisory Committee (ASDMAC) 43
Glossary 47
Appendices 49
Appendix A: Drug testing statistics 2002–2003 50
Appendix B: Register of Notifiable Events (RNE) 63
Appendix C: List of International Incidences (LII) 65
Appendix D: Entries on RNE and LII from previous years where outcomes
were to be advised 66
Appendix E: International anti-doping arrangements and drug-testing agreements 67
Appendix F: Financial statements 69
Appendix G: Powers of the Minister under the ASDA Act 111
Appendix H: The objects, functions and powers of the agency as specified in the
ASDA Act 113
Appendix I: Portfolio budget statements performance summary 114
Appendix J: Resources for portfolio budget statements 115
Appendix K: 2001–2005 ASDA Strategic Plan 116
Appendix L: ASDA Strategic Plan performance outcomes 2002–2003 117
Appendix M: ASDMAC functions 118
Appendix N: ASDMAC approvals by sport 2002–2003. 119
Index 121
CHAIRPERSON’S SUMMARY > ASDA ANNUAL REPORT 02:03 > PAGE V
Figures
Figure 1: Australia’s anti-doping framework 8
Figure 2: ASDA’s corporate structure 8
Figure 3: Register of notifiable events trends 1998 to 200 12
Figure 4: ASDA’s client engagement 14
Figure 5: Awareness of ASDA’s services 16
Figure 6: ASDA products distributed 17
Figure 7: Satisfaction with ASDA’s services 17
Figure 8: Effectiveness of ASDA’s international relationships 24
Figure 9: ASDA’s corporate governance — 2002 versus 2003 28
Figure 10: ASDA Board details as at 30 June 2003 36
Figure 11: ASDA Audit Committee details as at 30 June 2003 .38
Figure 12: ASDA staff per program statistics 40
Figure 13: ASDA staff per location statistics 40
Figure 14: Comparison of ASDA staffing levels 40
Figure 15: ASDMAC funding breakdown 46

USADA Annual Report 2002 / United States Anti-Doping Agency (USADA). - Colorado Springs : USADA, 2003

World Anti-Doping Agency 2002 annual report / World Anti-Doping Agency (WADA). - Montreal : WADA, 2003

CONTENTS
03 MESSAGE FROM THE CHAIRMAN
05 MESSAGE FROM THE DIRECTOR GENERAL
06 DEVELOPMENT OF THE WORLD ANTI-DOPING CODE
09 DOPING-CONTROL PROGRAM
13 INDEPENDENT OBSERVER PROGRAM
15 COMMUNICATIONS
17 ATHLETE OUTREACH
19 ADMINISTRATION
23 RESEARCH
24 FUNDING
26 FINANCE

History of Doping in Sport / Charles E. Yesalis, Michael S. Bahrke. - (International Sports Studies 24 (2002) 1; p. 42-76)

Abstract

Athletes have used a myriad of performance-enhancing substances since ancient times and this practice continues today. This review discusses the early history of doping in sport, the use of stimulants and anabolics during the nineteenth and twentieth centuries, the current use of performance-enhancing drugs by Olympic, professional, university and adolescent male and female athletes, as well as the response of organised sport to this problem.

AUSTRALIAN SPORTS DRUG AGENCY 2001-02 ANNUAL REPORT
© Commonwealth of Australia
ISSN 1037-378

Contents
Chairperson's Summary 7
2001-2002 Highlights 11
Australia's Anti-Doping Framework 15
Organisational Overview 17
ASDA at a Glance 18
Corporate Governance 18
ASDA Corporate Structure 25
Deterrence 27
Daig Testing 28
Education 32
Research 36
International Response 37
Facilitating Harmonised International Responses 38
Representing Australia Internationally 40
Business Improvement , 43
Effective Corporate Governance 44
Responding to Business Opportunities 45
Employing Best Practice Business 45
Community Service Obligations 46
People 47
Developing Staff Potential 48
Attracting and Retaining Staff 48
Learning and Development 50
Australian Sports Drug Medical Advisory Committee (ASDMAC) 51
Responsibilities. 52
ASDMAC Members 52
Approvals Process 54
Activities 55
International Trends 55
Funding 56
Glossary 57
Appendices 59
Appendix A - Powers of die Minister under the ASDA Act 60
Appendix B - The Objects, Functions and Powers of the Agency as Specified in die ASDA Act 61
Appendix C - Portfolio Budget Statements Outcomes and Outputs Performance Summary 63
Appendix D - Resources for Portfolio Budget Statements Outcome 1 64
Appendix E - 2001-2005 Strategic Plan 65
Appendix F - Strategic Plan Performance Outcomes Summary for 2001-2002 66
Appendix G - Financial Statements 67
Appendix H - Council of Europe Anti-Doping Convention's Monitoring Group compliance Report 117
Appendix I - Drug Testing for 2001-2002 120
Appendix J - Register of Notifiable Events 131
Appendix K - Entries on Register of Notifiable Eventsfrom Previous Years where Outcomes were to be advised 134
Appendix L - International List of Incidences 135
Appendix M - International Anti-Doping Arrangements and Drug Testing Agreements 136
Appendix N - Australian Sports Drug Medical Advisory Committee Functions 138
Appendix O - Australian Sports Drug Medical Advisory Committee Approvals 139
Index 141
Figures
Figure 1: Australia's Anti-Doping Framework
Figure 2: ASDA Board Details as at 30 June 2002
Figure 3: ASDA Audit Committee Details as at 30 June 2002
Figure 4: ASDA Staff by Gender
Figure 5: ASDA Staff by Location
Figure 6: ASDA Corporate Structure
Figure 7: ASDA Drug Testing Numbers
Figure 8: Government-Funded No-Advance-Notice & Blood Testing Target vs Completed Tests
Figure 9: Percentage of Clients Satisfied with ASDA services
Figure 10: Access to A5DA Education Services
Figure li t ASDA Performance against People Key Performance indicators

Anti-Doping controls and positives : statistical data 2001 / Comitato Olimpico Nazionale Italiano (CONI). - Roma : CONI, 2002